| Characteristic . | Total (n = 643) . | Euthyroid (n = 534) . |
|---|---|---|
| Age, y, mean (sd) | 85.5 (0.4) | 85.5 (0.4) |
| Male, % (n) | 42.0 (270) | 43.6 (233) |
| BMI, mean (sd) | 24.4 (4.4) | 24.5 (4.5) |
| Current smoker, % (n) | 5.6 (36) | 5.3 (28) |
| Basic education, % (n) | 63.6 (404) | 64.2 (339) |
| Living in care home, % (n) | 8.7 (56) | 8.6 (46) |
| Medical history, % (n) | ||
| Diabetes | 14.1 (91) | 14.2 (76) |
| Hypertension | 58.2 (374) | 59.0 (315) |
| IHD | 34.4 (221) | 37.3 (196) |
| Stroke | 13.8 (89) | 13.7 (73) |
| Cancer | 6.4 (41) | 6.2 (33) |
| Disease count, median (IQR) | 4 (3–6) | 4 (3–6) |
| Disability score, median (IQR) | 3 (1–7) | 3 (1–7) |
| MMSE score, median (IQR) | 28 (25–29) | 28 (25–29) |
| Fair or poor self-rated health, % (n) | 19.9 (120) | 20.9 (110) |
| Survival time, mo, median (IQR) | 65.6 (32.6–92.6) | 64.6 (32.4–91.1) |
| Deaths, % (n) | 68.4 (440) | 70.2 (375) |
| Cardiovascular deaths, % (n) | 39.2 (252) | 40.6 (217) |
| TSHa, mU/L | 1.87 (0.27–6.53) | 1.73 (0.58–3.80) |
| FT3a, pmol/L | 4.54 (3.60–5.5) | 4.52 (3.60–5.40) |
| FT4a, pmol/L | 15.20 (11.0–21.0) | 15.24 (11.0–20.0) |
| rT3a, nmol/L | 0.40 (0.25–0.67) | 0.40 (0.26–0.67) |
| TPOAbs positive, % (n) | 15.9 (102) | 12.6 (67) |
| Albumina, g/L | 40.03 (33.00–46.00) | 40.03 (33.00–46.00) |
| C reactive proteina, mg/L | 2.65 (0.30–52.20) | 2.67 (0.30–52.20) |
| Overt hypothyroid | 0.9 (6) | — |
| Subclinical hypothyroid | 12.3 (79) | — |
| Euthyroid | 83.1 (534) | 534 (100) |
| Subclinical hyperthyroid | 2.9 (19) | — |
| Overt hyperthyroid | 0.8 (5) | — |
| Characteristic . | Total (n = 643) . | Euthyroid (n = 534) . |
|---|---|---|
| Age, y, mean (sd) | 85.5 (0.4) | 85.5 (0.4) |
| Male, % (n) | 42.0 (270) | 43.6 (233) |
| BMI, mean (sd) | 24.4 (4.4) | 24.5 (4.5) |
| Current smoker, % (n) | 5.6 (36) | 5.3 (28) |
| Basic education, % (n) | 63.6 (404) | 64.2 (339) |
| Living in care home, % (n) | 8.7 (56) | 8.6 (46) |
| Medical history, % (n) | ||
| Diabetes | 14.1 (91) | 14.2 (76) |
| Hypertension | 58.2 (374) | 59.0 (315) |
| IHD | 34.4 (221) | 37.3 (196) |
| Stroke | 13.8 (89) | 13.7 (73) |
| Cancer | 6.4 (41) | 6.2 (33) |
| Disease count, median (IQR) | 4 (3–6) | 4 (3–6) |
| Disability score, median (IQR) | 3 (1–7) | 3 (1–7) |
| MMSE score, median (IQR) | 28 (25–29) | 28 (25–29) |
| Fair or poor self-rated health, % (n) | 19.9 (120) | 20.9 (110) |
| Survival time, mo, median (IQR) | 65.6 (32.6–92.6) | 64.6 (32.4–91.1) |
| Deaths, % (n) | 68.4 (440) | 70.2 (375) |
| Cardiovascular deaths, % (n) | 39.2 (252) | 40.6 (217) |
| TSHa, mU/L | 1.87 (0.27–6.53) | 1.73 (0.58–3.80) |
| FT3a, pmol/L | 4.54 (3.60–5.5) | 4.52 (3.60–5.40) |
| FT4a, pmol/L | 15.20 (11.0–21.0) | 15.24 (11.0–20.0) |
| rT3a, nmol/L | 0.40 (0.25–0.67) | 0.40 (0.26–0.67) |
| TPOAbs positive, % (n) | 15.9 (102) | 12.6 (67) |
| Albumina, g/L | 40.03 (33.00–46.00) | 40.03 (33.00–46.00) |
| C reactive proteina, mg/L | 2.65 (0.30–52.20) | 2.67 (0.30–52.20) |
| Overt hypothyroid | 0.9 (6) | — |
| Subclinical hypothyroid | 12.3 (79) | — |
| Euthyroid | 83.1 (534) | 534 (100) |
| Subclinical hyperthyroid | 2.9 (19) | — |
| Overt hyperthyroid | 0.8 (5) | — |
Abbreviations: IHD, ischemic heart disease; IQR, interquartile range; TPOAbs, thyroid peroxidase antibodies.
Geometric mean, 2.5–97.5th percentiles
| Characteristic . | Total (n = 643) . | Euthyroid (n = 534) . |
|---|---|---|
| Age, y, mean (sd) | 85.5 (0.4) | 85.5 (0.4) |
| Male, % (n) | 42.0 (270) | 43.6 (233) |
| BMI, mean (sd) | 24.4 (4.4) | 24.5 (4.5) |
| Current smoker, % (n) | 5.6 (36) | 5.3 (28) |
| Basic education, % (n) | 63.6 (404) | 64.2 (339) |
| Living in care home, % (n) | 8.7 (56) | 8.6 (46) |
| Medical history, % (n) | ||
| Diabetes | 14.1 (91) | 14.2 (76) |
| Hypertension | 58.2 (374) | 59.0 (315) |
| IHD | 34.4 (221) | 37.3 (196) |
| Stroke | 13.8 (89) | 13.7 (73) |
| Cancer | 6.4 (41) | 6.2 (33) |
| Disease count, median (IQR) | 4 (3–6) | 4 (3–6) |
| Disability score, median (IQR) | 3 (1–7) | 3 (1–7) |
| MMSE score, median (IQR) | 28 (25–29) | 28 (25–29) |
| Fair or poor self-rated health, % (n) | 19.9 (120) | 20.9 (110) |
| Survival time, mo, median (IQR) | 65.6 (32.6–92.6) | 64.6 (32.4–91.1) |
| Deaths, % (n) | 68.4 (440) | 70.2 (375) |
| Cardiovascular deaths, % (n) | 39.2 (252) | 40.6 (217) |
| TSHa, mU/L | 1.87 (0.27–6.53) | 1.73 (0.58–3.80) |
| FT3a, pmol/L | 4.54 (3.60–5.5) | 4.52 (3.60–5.40) |
| FT4a, pmol/L | 15.20 (11.0–21.0) | 15.24 (11.0–20.0) |
| rT3a, nmol/L | 0.40 (0.25–0.67) | 0.40 (0.26–0.67) |
| TPOAbs positive, % (n) | 15.9 (102) | 12.6 (67) |
| Albumina, g/L | 40.03 (33.00–46.00) | 40.03 (33.00–46.00) |
| C reactive proteina, mg/L | 2.65 (0.30–52.20) | 2.67 (0.30–52.20) |
| Overt hypothyroid | 0.9 (6) | — |
| Subclinical hypothyroid | 12.3 (79) | — |
| Euthyroid | 83.1 (534) | 534 (100) |
| Subclinical hyperthyroid | 2.9 (19) | — |
| Overt hyperthyroid | 0.8 (5) | — |
| Characteristic . | Total (n = 643) . | Euthyroid (n = 534) . |
|---|---|---|
| Age, y, mean (sd) | 85.5 (0.4) | 85.5 (0.4) |
| Male, % (n) | 42.0 (270) | 43.6 (233) |
| BMI, mean (sd) | 24.4 (4.4) | 24.5 (4.5) |
| Current smoker, % (n) | 5.6 (36) | 5.3 (28) |
| Basic education, % (n) | 63.6 (404) | 64.2 (339) |
| Living in care home, % (n) | 8.7 (56) | 8.6 (46) |
| Medical history, % (n) | ||
| Diabetes | 14.1 (91) | 14.2 (76) |
| Hypertension | 58.2 (374) | 59.0 (315) |
| IHD | 34.4 (221) | 37.3 (196) |
| Stroke | 13.8 (89) | 13.7 (73) |
| Cancer | 6.4 (41) | 6.2 (33) |
| Disease count, median (IQR) | 4 (3–6) | 4 (3–6) |
| Disability score, median (IQR) | 3 (1–7) | 3 (1–7) |
| MMSE score, median (IQR) | 28 (25–29) | 28 (25–29) |
| Fair or poor self-rated health, % (n) | 19.9 (120) | 20.9 (110) |
| Survival time, mo, median (IQR) | 65.6 (32.6–92.6) | 64.6 (32.4–91.1) |
| Deaths, % (n) | 68.4 (440) | 70.2 (375) |
| Cardiovascular deaths, % (n) | 39.2 (252) | 40.6 (217) |
| TSHa, mU/L | 1.87 (0.27–6.53) | 1.73 (0.58–3.80) |
| FT3a, pmol/L | 4.54 (3.60–5.5) | 4.52 (3.60–5.40) |
| FT4a, pmol/L | 15.20 (11.0–21.0) | 15.24 (11.0–20.0) |
| rT3a, nmol/L | 0.40 (0.25–0.67) | 0.40 (0.26–0.67) |
| TPOAbs positive, % (n) | 15.9 (102) | 12.6 (67) |
| Albumina, g/L | 40.03 (33.00–46.00) | 40.03 (33.00–46.00) |
| C reactive proteina, mg/L | 2.65 (0.30–52.20) | 2.67 (0.30–52.20) |
| Overt hypothyroid | 0.9 (6) | — |
| Subclinical hypothyroid | 12.3 (79) | — |
| Euthyroid | 83.1 (534) | 534 (100) |
| Subclinical hyperthyroid | 2.9 (19) | — |
| Overt hyperthyroid | 0.8 (5) | — |
Abbreviations: IHD, ischemic heart disease; IQR, interquartile range; TPOAbs, thyroid peroxidase antibodies.
Geometric mean, 2.5–97.5th percentiles
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
